hydrochlorothiazide and azilsartan

hydrochlorothiazide has been researched along with azilsartan in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Barrios, V; Escobar, C	1
Nishiyama, Y; Rakugi, H; Sano, Y; Shimizu, K; Umeda, Y	1
Kinugawa, Y; Nishiyama, Y; Rakugi, H; Sano, Y; Shimizu, K; Terashio, S	1
van der Merwe, WM	1

Reviews

1 review(s) available for hydrochlorothiazide and azilsartan

Article	Year
Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker? Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:16 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Chlorthalidone; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Oxadiazoles	2013

Trials

2 trial(s) available for hydrochlorothiazide and azilsartan

Article	Year
A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension. Blood pressure, 2018, Volume: 27, Issue:3 Topics: Adult; Aged; Amlodipine; Benzimidazoles; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Oxadiazoles	2018
Effects of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide on office/home blood pressure: a randomized-controlled trial in Japanese essential hypertensive patients. Blood pressure monitoring, 2018, Volume: 23, Issue:2 Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Japan; Male; Middle Aged; Oxadiazoles; Treatment Outcome	2018

Article

Year

A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension.

Blood pressure, 2018, Volume: 27, Issue:3

Topics: Adult; Aged; Amlodipine; Benzimidazoles; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Oxadiazoles

2018

Effects of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide on office/home blood pressure: a randomized-controlled trial in Japanese essential hypertensive patients.

Blood pressure monitoring, 2018, Volume: 23, Issue:2

Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Japan; Male; Middle Aged; Oxadiazoles; Treatment Outcome

2018

Other Studies

2 other study(ies) available for hydrochlorothiazide and azilsartan

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Treatment of hypertension in CKD patients with azilsartan/chlorthalidone vs olmesartan/hydrochlorothiazide. Journal of clinical hypertension (Greenwich, Conn.), 2018, Volume: 20, Issue:4 Topics: Antihypertensive Agents; Benzimidazoles; Chlorthalidone; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Renal Insufficiency, Chronic; Tetrazoles	2018